tni insect cells Search Results


tni insect cells  (CinnaGen Co)
90
CinnaGen Co tni insect cells
Several recombinant protein vaccines against COVID-19 in clinical trials and pre-clinical studies as of 25 October 2022.
Tni Insect Cells, supplied by CinnaGen Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tni+insect+cells/pmc09863728-14-17-5?v=CinnaGen+Co
Average 90 stars, based on 1 article reviews
tni insect cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
tni insect cells  (Vaxine Pty Ltd)
90
Vaxine Pty Ltd tni insect cells
Several recombinant protein vaccines against COVID-19 in clinical trials and pre-clinical studies as of 25 October 2022.
Tni Insect Cells, supplied by Vaxine Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tni+insect+cells/pmc09863728-14-17-0?v=Vaxine+Pty+Ltd
Average 90 stars, based on 1 article reviews
tni insect cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Several recombinant protein vaccines against COVID-19 in clinical trials and pre-clinical studies as of 25 October 2022.

Journal: International Journal of Molecular Sciences

Article Title: Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress

doi: 10.3390/ijms24021701

Figure Lengend Snippet: Several recombinant protein vaccines against COVID-19 in clinical trials and pre-clinical studies as of 25 October 2022.

Article Snippet: Vaxine Pty Ltd. (Adelaide, Australia)/ CinnaGen Co. (Tehran, Iran) , COVAX-19 (SpikoGen) , S protein ectodomain , Tni insect cells , Advax-CpG55.2 (Advax-SM) , 3 (NCT05005559, NCT05542862 and NCT05175625) , Iran , [ , , ] .

Techniques: Recombinant, Expressing, Plasmid Preparation, Synthesized

Several recombinant protein vaccines against COVID-19 in clinical trials and pre-clinical studies as of 25 October 2022.

Journal: International Journal of Molecular Sciences

Article Title: Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress

doi: 10.3390/ijms24021701

Figure Lengend Snippet: Several recombinant protein vaccines against COVID-19 in clinical trials and pre-clinical studies as of 25 October 2022.

Article Snippet: Vaxine Pty Ltd. (Adelaide, Australia)/ CinnaGen Co. (Tehran, Iran) , COVAX-19 (SpikoGen) , S protein ectodomain , Tni insect cells , Advax-CpG55.2 (Advax-SM) , 3 (NCT05005559, NCT05542862 and NCT05175625) , Iran , [ , , ] .

Techniques: Recombinant, Expressing, Plasmid Preparation, Synthesized